Hjem › Livmoderslimhindekræft › Indiana
Livmoderslimhindekræft kliniske forsøg i Indiana
19 studier for Livmoderslimhindekræft søger deltagere på steder i Indiana.
Byer i Indiana
Officiel studietekst (engelsk)
Targeted Therapy Directed by Genetic Testing in Treating Patients With Locally Advanced or Advanced Solid Tumors, The ComboMATCH Screening Trial
- UChicago Medicine Northwest Indiana, Crown Point
- Woodland Cancer Care Center, Michigan City
RekruttererFase 2
Alle aldre · Alle køn · Opdateret 2. okt. 2026 · NCT05564377Testing the Addition of an Antiangiogenic Drug (Bevacizumab) to Chemotherapy (Carboplatin and Paclitaxel) Combined With Immunotherapy (Pembrolizumab) for pMMR, TP53 Mutated Endometrial Cancer
- UChicago Medicine Northwest Indiana, Crown Point
- Goshen Center for Cancer Care, Goshen
- Ascension Saint Vincent Indianapolis Hospital, Indianapolis
RekruttererFase 3
Alder 18 og opefter · Kvinder · Opdateret 2. okt. 2026 · NCT07198074Testing Nivolumab With or Without Ipilimumab in Deficient Mismatch Repair System (dMMR) Recurrent Endometrial Carcinoma
- Northwest Cancer Center - Crown Point, Crown Point
- Northwest Oncology LLC, Dyer
- Northwest Cancer Center - Hobart, Hobart
- og 6 flere
RekruttererFase 2
Alder 18 og opefter · Kvinder · Opdateret 28. sep. 2026 · NCT05112601Adjuvant Therapy in POLE-Mutated and p53-Wildtype/NSMP Early Stage Endometrial Cancer RAINBO BLUE & TAPER
- Ascension Saint Vincent Indianapolis Hospital, Indianapolis
RekruttererFase 2
Alder 18 og opefter · Kvinder · Opdateret 24. sep. 2026 · NCT05640999Study of Elironrasib and Daraxonrasib as Monotherapies and Combination Therapy in Participants With Advanced KRAS G12C Mutant Solid Tumors
- Community Health Network, Indianapolis
RekruttererFase 1/2
Alder 18 og opefter · Alle køn · Opdateret 22. sep. 2026 · NCT06128551A Study to Compare Sacituzumab Tirumotecan (MK-2870) in Combination With Pembrolizumab (MK-3475) Versus Pembrolizumab Alone as Treatment in Participants With Mismatch Repair Proficient Endometrial Cancer (MK-2870-033/TroFuse-033/GOG-3119/ENGOT-en29)
- Parkview Research Center ( Site 6008), Fort Wayne
RekruttererFase 3
Alder 18 og opefter · Kvinder · Opdateret 17. sep. 2026 · NCT06952504Phase 1, Safety and Tolerability Study of XmAb541 in Advanced Solid Tumors
- Indiana University Melvin and Bren Simon Comprehensive Cancer Center, Indianapolis
RekruttererFase 1
Alder 15 og opefter · Alle køn · Opdateret 25. aug. 2026 · NCT06276491Tegavivint for the Treatment of Recurrent or Refractory Solid Tumors, Including Lymphomas and Desmoid Tumors
- Riley Hospital for Children, Indianapolis
RekruttererFase 1/2
12 Months – 30 Years · Alle køn · Opdateret 25. aug. 2026 · NCT04851119A Study to Test How Well Different Doses of BI 3820768 Are Tolerated by People With Advanced Cancer (Solid Tumours)
- Indiana University, Indianapolis
RekruttererFase 1
Alder 18 og opefter · Alle køn · Opdateret 21. aug. 2026 · NCT07306559A Phase 2 Study of ACR-368 in Endometrial Adenocarcinoma
- Ascension St. Vicent Hospital, Inc., Indianapolis
RekruttererFase 2
Alder 18 og opefter · Kvinder · Opdateret 21. aug. 2026 · NCT05548296A Study of ART0380 for the Treatment of Advanced or Metastatic Solid Tumors
- Community Health Network, Indianapolis
RekruttererFase 1/2
Alder 18 og opefter · Alle køn · Opdateret 30. jul. 2026 · NCT04657068Puxitatug Samrotecan (AZD8205) Monotherapy vs Chemotherapy in B7-H4-selected Endometrial Cancer (Bluestar-Endometrial01)
- Research Site, Fort Wayne
- Research Site, Indianapolis
RekruttererFase 3
Alder 18 og opefter · Kvinder · Opdateret 29. jul. 2026 · NCT07044336Study of Trastuzumab Deruxtecan Versus Standard of Care Chemotherapy for HER2-Expressing (IHC 3+/2+) Endometrial Cancer
- Parkview Research Center, Fort Wayne
RekruttererFase 3
Alder 18 og opefter · Kvinder · Opdateret 28. jul. 2026 · NCT07022483Integrated Cancer Repository for Cancer Research
- Parkview Research Center, Fort Wayne
RekruttererObservationsstudieFrivillige med god helbredstilstand velkomne
Alder 19 til 110 · Alle køn · Opdateret 29. jun. 2026 · NCT02012699A Study of LY4175408 in Participants With Advanced Cancer
- Community Health Network, Indianapolis
RekruttererFase 1
Alder 18 og opefter · Alle køn · Opdateret 23. jun. 2026 · NCT07046923cfDNA Assay Prospective Observational Validation for Early Cancer Detection and Minimal Residual Disease
- Baptist Floyd, New Albany
RekruttererObservationsstudieFrivillige med god helbredstilstand velkomne
Alder 40 og opefter · Alle køn · Opdateret 20. jan. 2026 · NCT05366881A Phase I/II Study of VLS-1488 in Subjects With Advanced Cancer
- Community Health Network, Indianapolis
RekruttererFase 1/2
Alder 18 og opefter · Alle køn · Opdateret 4. nov. 2025 · NCT05902988A Study of GV20-0251 Monotherapy and GV20-0251 in Combination With Pembrolizumab in Participants With Solid Tumor Malignancies
- Community Health Network, Inc., Indianapolis
RekruttererFase 1/2
Alder 18 og opefter · Alle køn · Opdateret 13. feb. 2025 · NCT05669430Study of Navtemadlin as Maintenance Therapy in TP53WT Advanced or Recurrent Endometrial Cancer
- Parkview Research Center, Fort Wayne
- Indiana University, Indianapolis
RekruttererFase 2/3
Alder 18 og opefter · Kvinder · Opdateret 2. maj 2024 · NCT05797831Fra ClinicalTrials.gov, data hentet 5. okt. 2026. Hver studie har sine egne kvalifikationskrav; studieteamet afgør, hvem der kan deltage.